Zoetis (MEX:ZTS) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ZTS Zoetis Inc MEX:ZTS
69 GF Score
Price MXN1,305.00
GF Value MXN3,427.85
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:ZTS
69GF Score
Zoetis Inc MEX:ZTS
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zoetis (MEX:ZTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of MXN1,305.00 is trading 61.9% below its estimated GF Value™ of MXN3,427.85. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for MEX:ZTS:

  • Short Ratio:
  • GF Value™: MXN3,427.85 vs. price of MXN1,305.00 (61.9% below fair value)
  • GF Score™: 69/100

No single metric tells the full story. See the MEX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
69GF Score

Get the complete analysis for MEX:ZTS

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,305.00
Price
MXN3,427.85
GF Value